Drug sales in four European countries still differBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7428.1404-c (Published 11 December 2003) Cite this as: BMJ 2003;327:1404
- Silvio Garattini (email@example.com), director,
- Livio Garattini, chief
- Istituto di Ricerche Farmacologiche “Mario Negri,” Via Eritrea, 62, I-20157 Milan, Italy
- Centro di Economia Sanitaria Angelo e Angela Valenti, Villa Camozzi, Ranica (BG), Italy
EDITOR—The box shows, by value, the top selling pharmaceutical products that are common to Italy, France, Germany, and the United Kingdom. In 1992,1 1996,2 and 2001 few products were prescribed in all four countries. Nineteen active substances were common to three countries, 17 to two countries, and 63 were on only one country's list.
Several classes of drugs were represented in all four countries but with different products. For example, angiotensin converting enzyme inhibitors were prescribed …